Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Inventory (2016 - 2025)

SRx Health Solutions' Inventory history spans 10 years, with the latest figure at $2.1 million for Q3 2025.

  • For Q3 2025, Inventory fell 38.32% year-over-year to $2.1 million; the TTM value through Sep 2025 reached $2.1 million, down 38.32%, while the annual FY2025 figure was $2.1 million, N/A changed from the prior year.
  • Inventory reached $2.1 million in Q3 2025 per SRXH's latest filing, down from $5.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $11.6 million in Q3 2022 to a low of $2.1 million in Q3 2025.
  • Average Inventory over 5 years is $6.3 million, with a median of $5.2 million recorded in 2021.
  • Peak YoY movement for Inventory: skyrocketed 239.11% in 2022, then crashed 58.95% in 2024.
  • A 5-year view of Inventory shows it stood at $5.2 million in 2021, then soared by 95.56% to $10.3 million in 2022, then crashed by 35.55% to $6.6 million in 2023, then plummeted by 41.48% to $3.9 million in 2024, then crashed by 46.29% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Inventory are $2.1 million (Q3 2025), $5.1 million (Q2 2025), and $4.5 million (Q1 2025).